Upcoming Events

 AcademyHealth

National Health Policy Conference

February 13-14

American College of Preventive Medicine

Preventive Medicine 2012  

February 22-25

National STD Prevention Conference

March 12-15

22nd Annual Art and Science of Health Promotion Conference 

April 11-13 

Connect with Us

Partnership Pulse

Partnership's ActionToQuit initiative funded research

that found a comprehensive tobacco cessation

benefit saves Medicaid $3.12 for every $1 spent, resulting in a net return on investment of $2.12. Researchers at George Washington University studied data from the Massachusetts Medicaid program to determine the costs of a benefit to help beneficiaries quit using tobacco, as well as short-term savings to the program. The research was published in the open-access journal PLoS ONE. ActionToQuit also released a policy paper that discusses the policy implications of increased Medicaid coverage of comprehensive tobacco cessation treatment.

ActionToQuit is hosting a free webinar on Wednesday, February 8 from 2:00 - 3:15 pm (ET) about this research. Register for the webinar here.

The National Chlamydia Coalition (NCC) held its annual meeting

January 26 and 27 in Washington, DC. Featured speakers included Marc Garufi from the Office of Management and Budget (OMB) and Dr. Michael Horberg, who is with Kaiser Permanente and is a member of the President's Advisory Council on HIV/AIDS. The NCC held roundtable discussions on current hot topics and breakout sessions for committee meetings. Ashley Coffield, Partnership's director of the NCC and a new coalition to promote sexual health, moderated the meeting. Visit www.prevent.org/ncc to learn more about the NCC and find resources about chlamydia and other sexual health issues.

Partnership's Aspirin Council Holds Annual Meeting

Partnership's Council on Aspirin for Health and Prevention held its annual meeting in Yountville, CA from January 26-28th. The meeting's guest speaker, Dr. Thomas Bersot, from the University of California, San Francisco, discussed the role of personalized medicine in cardiovascular disease prevention. The Council also discussed the scope and direction of its 2012 work plan. In the coming year, the Council will update research on attitudes toward aspirin and tools to promote aspirin use, and advance policies that promote the appropriate use of aspirin.

Jennifer Jenson, a managing senior fellow at Partnership, has been serving on an Institute of Medicine (IOM) committee that is tasked with developing a framework for assessing the value of community-based prevention policies and wellness strategies.  The group met in January to continue its work on the project, including detailing the wide array of health, economic and other benefits from community prevention for individuals, populations, and the communities in which they live. Jenson was appointed to the IOM committee based on her experience leading Partnership's National Commission on Prevention Priorities, which has done related work, and her background analyzing the federal budget impact of prevention policies.

Partnership's Chief Medical Officer, Dr. Jason Spangler, spoke at the Policy Action Gathering of the National Forum for Heart Disease and Stroke Prevention. Dr. Spangler explained the new Medicare benefit for Intensive Behavioral Therapy for Cardiovascular Disease, which includes aspirin counseling, and highlighted the development process of the new benefit. He also suggested lessons learned to assist in translating clinical preventive services into coverage in essential health benefits and state health insurance exchanges. 

ActionToQuit urged the National Quality Forum (NQF) to endorse all four Joint Commission inpatient tobacco measures. The NQF's support will have a significant impact on tobacco dependence treatment in U.S hospitals. Among its many functions, the NQF provides input to the Department of Health and Human Services in the selection of performance measures for public reporting and performance-based payment programs.